Metavone’s Aims:
Metavone’s business model is focused on further research and development of the Isoflavone Drug Technology compounds in further pre-clinical testing (whether by computer-based modelling, laboratory or animal trials) and then clinical trials in humans so as to identify and then commercially develop therapeutic dementia treatments for dementia conditions and as a dementia preventative product, as well as developing therapeutic hormone-related cancer treatments